Caligan Partners LP 13D and 13G filings for Standard BioTools Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-08 5:00 pm Sale | 2024-01-05 | 13D | Standard BioTools Inc. LAB | Caligan Partners LP | 7,042,413 2.400% | -755,041 (-9.68%) | Filing |
| 2023-07-03 5:17 pm Sale | 2023-07-03 | 13D | Standard BioTools Inc. LAB | Caligan Partners LP | 7,797,454 9.900% | -779,345 (-9.09%) | Filing |
| 2022-12-30 5:10 pm Sale | 2022-12-29 | 13D | Standard BioTools Inc. LAB | Caligan Partners LP | 8,576,799 10.800% | -2,868,037 (-25.06%) | Filing |
| 2022-08-05 11:13 am Purchase | 2022-08-04 | 13D | Standard BioTools Inc. LAB | Caligan Partners LP | 11,444,836 14.800% | 1,021,648 (+9.80%) | Filing |
| 2022-06-07 10:31 am Purchase | 2022-06-03 | 13D | Standard BioTools Inc. LAB | Caligan Partners LP | 10,423,188 13.500% | 938,350 (+9.89%) | Filing |
| 2022-05-03 12:40 pm Purchase | 2022-04-29 | 13D | Standard BioTools Inc. LAB | Caligan Partners LP | 9,484,838 12.300% | 1,104,573 (+13.18%) | Filing |
| 2022-03-29 5:14 pm Unchanged | 2022-03-29 | 13D | Standard BioTools Inc. LAB | Caligan Partners LP | 8,380,265 10.900% | 0 (Unchanged) | Filing |
| 2021-05-10 5:20 pm Purchase | 2021-04-30 | 13D | Standard BioTools Inc. LAB | Caligan Partners LP | 8,380,265 11.200% | 8,380,265 (New Position) | Filing |